ICD120J ;ALB/RFS - YEARLY DRG UPDATE; August 15, 2024@15:24
 ;;18.0;DRG Grouper;**120**;October 20, 2000;Build 4
 ;Per VA Directive 6402, this routine should not be modified.
 ;Updates for DRGS 640-809
 Q
 ;
MSDRG ;;MS-DRG^MDC^TYPE^MS-DRG TITLE^WEIGHTS^GEOMETRIC MEAN LOS
 ;;640^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITH MCC^1.3281^3.6^5
 ;;641^10^MED^MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM, FLUIDS AND ELECTROLYTES WITHOUT MCC^0.7815^2.6^3.3
 ;;642^10^MED^INBORN AND OTHER DISORDERS OF METABOLISM^1.2411^3.2^4.5
 ;;643^10^MED^ENDOCRINE DISORDERS WITH MCC^1.6573^5^6.4
 ;;644^10^MED^ENDOCRINE DISORDERS WITH CC^1.0335^3.4^4.2
 ;;645^10^MED^ENDOCRINE DISORDERS WITHOUT CC/MCC^0.779^2.6^3.2
 ;;650^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITH MCC^4.607^6.3^8
 ;;651^11^SURG^KIDNEY TRANSPLANT WITH HEMODIALYSIS WITHOUT MCC^3.4722^5.4^6.1
 ;;652^11^SURG^KIDNEY TRANSPLANT^3.0712^4.3^4.8
 ;;653^11^SURG^MAJOR BLADDER PROCEDURES WITH MCC^5.5742^10.1^13.8
 ;;654^11^SURG^MAJOR BLADDER PROCEDURES WITH CC^2.8219^5.3^6.4
 ;;655^11^SURG^MAJOR BLADDER PROCEDURES WITHOUT CC/MCC^2.0772^3.3^3.9
 ;;656^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH MCC^3.2577^5.1^7.4
 ;;657^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC^1.828^2.6^3.4
 ;;658^11^SURG^KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC^1.5039^1.7^1.9
 ;;659^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH MCC^2.5842^5.8^8
 ;;660^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC^1.3399^2.9^3.7
 ;;661^11^SURG^KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC^1.0266^1.8^2.1
 ;;662^11^SURG^MINOR BLADDER PROCEDURES WITH MCC^3.1194^7.2^10
 ;;663^11^SURG^MINOR BLADDER PROCEDURES WITH CC^1.5273^3.5^4.7
 ;;664^11^SURG^MINOR BLADDER PROCEDURES WITHOUT CC/MCC^1.0798^1.7^2.1
 ;;665^11^SURG^PROSTATECTOMY WITH MCC^3.4334^7.9^10.8
 ;;666^11^SURG^PROSTATECTOMY WITH CC^1.6472^3.6^4.9
 ;;667^11^SURG^PROSTATECTOMY WITHOUT CC/MCC^1.0277^1.8^2.3
 ;;668^11^SURG^TRANSURETHRAL PROCEDURES WITH MCC^2.9161^7.2^9.9
 ;;669^11^SURG^TRANSURETHRAL PROCEDURES WITH CC^1.5475^3.7^4.9
 ;;670^11^SURG^TRANSURETHRAL PROCEDURES WITHOUT CC/MCC^0.9556^1.9^2.4
 ;;671^11^SURG^URETHRAL PROCEDURES WITH CC/MCC^1.7236^4.2^5.9
 ;;672^11^SURG^URETHRAL PROCEDURES WITHOUT CC/MCC^1.0943^1.5^1.8
 ;;673^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH MCC^4.19^10.4^13.5
 ;;674^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITH CC^2.3083^5.5^7.3
 ;;675^11^SURG^OTHER KIDNEY AND URINARY TRACT PROCEDURES WITHOUT CC/MCC^1.5652^2.9^3.8
 ;;682^11^MED^RENAL FAILURE WITH MCC^1.502^4.4^5.8
 ;;683^11^MED^RENAL FAILURE WITH CC^0.8889^3^3.8
 ;;684^11^MED^RENAL FAILURE WITHOUT CC/MCC^0.6075^2.2^2.6
 ;;686^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH MCC^1.8856^5.3^7.3
 ;;687^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITH CC^1.0526^3.2^4.2
 ;;688^11^MED^KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC^0.7242^1.8^2.3
 ;;689^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITH MCC^1.1704^3.8^5
 ;;690^11^MED^KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MCC^0.8026^2.8^3.5
 ;;693^11^MED^URINARY STONES WITH MCC^1.4703^3.8^5.3
 ;;694^11^MED^URINARY STONES WITHOUT MCC^0.7814^2.1^2.7
 ;;695^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITH MCC^1.1277^3.6^4.7
 ;;696^11^MED^KIDNEY AND URINARY TRACT SIGNS AND SYMPTOMS WITHOUT MCC^0.6917^2.3^2.9
 ;;697^11^MED^URETHRAL STRICTURE^0.9728^2.6^3.4
 ;;698^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MCC^1.6809^4.8^6.3
 ;;699^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH CC^1.0198^3.2^4
 ;;700^11^MED^OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITHOUT CC/MCC^0.6941^2.2^2.8
 ;;707^12^SURG^MAJOR MALE PELVIC PROCEDURES WITH CC/MCC^1.9405^2.2^3.2
 ;;708^12^SURG^MAJOR MALE PELVIC PROCEDURES WITHOUT CC/MCC^1.4824^1.3^1.5
 ;;709^12^SURG^PENIS PROCEDURES WITH CC/MCC^2.247^4.1^7
 ;;710^12^SURG^PENIS PROCEDURES WITHOUT CC/MCC^1.5013^1.7^2.3
 ;;711^12^SURG^TESTES PROCEDURES WITH CC/MCC^1.9075^4.7^6.7
 ;;712^12^SURG^TESTES PROCEDURES WITHOUT CC/MCC^0.8861^2.1^2.7
 ;;713^12^SURG^TRANSURETHRAL PROSTATECTOMY WITH CC/MCC^1.4459^2.5^3.6
 ;;714^12^SURG^TRANSURETHRAL PROSTATECTOMY WITHOUT CC/MCC^0.9396^1.5^1.7
 ;;715^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITH CC/MCC^2.2582^5.4^8.1
 ;;716^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES FOR MALIGNANCY WITHOUT CC/MCC^1.4192^1.5^1.8
 ;;717^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITH CC/MCC^1.8554^3.4^4.9
 ;;718^12^SURG^OTHER MALE REPRODUCTIVE SYSTEM O.R. PROCEDURES EXCEPT MALIGNANCY WITHOUT CC/MCC^1.2318^1.9^2.4
 ;;722^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH MCC^1.7288^5^7.2
 ;;723^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITH CC^1.1229^3.4^4.7
 ;;724^12^MED^MALIGNANCY, MALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6568^2^3.3
 ;;725^12^MED^BENIGN PROSTATIC HYPERTROPHY WITH MCC^1.2631^3.9^5.3
 ;;726^12^MED^BENIGN PROSTATIC HYPERTROPHY WITHOUT MCC^0.7443^2.4^3.1
 ;;727^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITH MCC^1.4693^4.5^6
 ;;728^12^MED^INFLAMMATION OF THE MALE REPRODUCTIVE SYSTEM WITHOUT MCC^0.8171^2.9^3.6
 ;;729^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITH CC/MCC^1.1008^3.1^4.4
 ;;730^12^MED^OTHER MALE REPRODUCTIVE SYSTEM DIAGNOSES WITHOUT CC/MCC^0.6069^1.8^2.2
 ;;734^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITH CC/MCC^2.1027^3^4.4
 ;;735^13^SURG^PELVIC EVISCERATION, RADICAL HYSTERECTOMY AND RADICAL VULVECTOMY WITHOUT CC/MCC^1.2138^1.6^1.8
 ;;736^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC^3.9373^7.5^9.6
 ;;737^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC^1.9983^3.7^4.6
 ;;738^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.5168^2.2^2.6
 ;;739^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC^3.9807^6.4^9.6
 ;;740^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC^1.8182^2.7^3.6
 ;;741^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC^1.3735^1.5^1.8
 ;;742^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITH CC/MCC^1.8266^2.7^3.9
 ;;743^13^SURG^UTERINE AND ADNEXA PROCEDURES FOR NON-MALIGNANCY WITHOUT CC/MCC^1.1986^1.5^1.7
 ;;744^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITH CC/MCC^1.9539^4.5^6.6
 ;;745^13^SURG^D&C, CONIZATION, LAPAROSCOPY AND TUBAL INTERRUPTION WITHOUT CC/MCC^1.0248^1.9^2.2
 ;;746^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITH CC/MCC^1.6745^3^4.9
 ;;747^13^SURG^VAGINA, CERVIX AND VULVA PROCEDURES WITHOUT CC/MCC^0.9551^1.3^1.5
 ;;748^13^SURG^FEMALE REPRODUCTIVE SYSTEM RECONSTRUCTIVE PROCEDURES^1.3622^1.4^1.8
 ;;749^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITH CC/MCC^2.5884^5.3^7.4
 ;;750^13^SURG^OTHER FEMALE REPRODUCTIVE SYSTEM O.R. PROCEDURES WITHOUT CC/MCC^1.2895^1.9^2.3
 ;;754^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.8092^5.1^7
 ;;755^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.1101^3.2^4.4
 ;;756^13^MED^MALIGNANCY, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.9549^2^2.4
 ;;757^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH MCC^1.4152^4.8^6.3
 ;;758^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITH CC^1.0193^3.5^4.5
 ;;759^13^MED^INFECTIONS, FEMALE REPRODUCTIVE SYSTEM WITHOUT CC/MCC^0.6399^2.6^3
 ;;760^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITH CC/MCC^0.9855^2.8^3.7
 ;;761^13^MED^MENSTRUAL AND OTHER FEMALE REPRODUCTIVE SYSTEM DISORDERS WITHOUT CC/MCC^0.6339^1.9^2.3
 ;;768^14^SURG^VAGINAL DELIVERY WITH O.R. PROCEDURES EXCEPT STERILIZATION AND/OR D&C^1.0111^2.7^3.1
 ;;769^14^SURG^POSTPARTUM AND POST ABORTION DIAGNOSES WITH O.R. PROCEDURES^1.3763^2.8^3.8
 ;;770^14^SURG^ABORTION WITH D&C, ASPIRATION CURETTAGE OR HYSTEROTOMY^1.0759^2.1^3
 ;;776^14^MED^POSTPARTUM AND POST ABORTION DIAGNOSES WITHOUT O.R. PROCEDURES^0.7134^2.3^2.9
 ;;779^14^MED^ABORTION WITHOUT D&C^0.9347^2.4^3.3
 ;;783^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH MCC^1.842^4.6^6.8
 ;;784^14^SURG^CESAREAN SECTION WITH STERILIZATION WITH CC^1.083^3.1^4.3
 ;;785^14^SURG^CESAREAN SECTION WITH STERILIZATION WITHOUT CC/MCC^0.8749^2.5^2.9
 ;;786^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH MCC^1.6158^4.2^6.4
 ;;787^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITH CC^1.0618^3.3^4
 ;;788^14^SURG^CESAREAN SECTION WITHOUT STERILIZATION WITHOUT CC/MCC^0.905^2.9^3.3
 ;;789^15^MED^NEONATES, DIED OR TRANSFERRED TO ANOTHER ACUTE CARE FACILITY^1.8027^1.8^1.8
 ;;790^15^MED^EXTREME IMMATURITY OR RESPIRATORY DISTRESS SYNDROME, NEONATE^5.945^17.9^17.9
 ;;791^15^MED^PREMATURITY WITH MAJOR PROBLEMS^4.0601^13.3^13.3
 ;;792^15^MED^PREMATURITY WITHOUT MAJOR PROBLEMS^2.4498^8.6^8.6
 ;;793^15^MED^FULL TERM NEONATE WITH MAJOR PROBLEMS^4.1706^4.7^4.7
 ;;794^15^MED^NEONATE WITH OTHER SIGNIFICANT PROBLEMS^1.4762^3.4^3.4
 ;;795^15^MED^NORMAL NEWBORN^0.1998^3.1^3.1
 ;;796^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH MCC^1.0609^2.9^3.5
 ;;797^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITH CC^0.9682^2.3^2.7
 ;;798^14^SURG^VAGINAL DELIVERY WITH STERILIZATION AND/OR D&C WITHOUT CC/MCC^0.9682^2.3^2.7
 ;;799^16^SURG^SPLENIC PROCEDURES WITH MCC^4.7545^7.2^9.9
 ;;800^16^SURG^SPLENIC PROCEDURES WITH CC^2.9136^4.4^6
 ;;801^16^SURG^SPLENIC PROCEDURES WITHOUT CC/MCC^1.6417^2.5^2.9
 ;;802^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MCC^3.5846^7.5^10.8
 ;;803^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH CC^1.7799^3.9^5.5
 ;;804^16^SURG^OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITHOUT CC/MCC^1.1055^1.7^2.3
 ;;805^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH MCC^0.9979^2.8^4.2
 ;;806^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITH CC^0.7235^2.3^2.6
 ;;807^14^MED^VAGINAL DELIVERY WITHOUT STERILIZATION OR D&C WITHOUT CC/MCC^0.6372^2^2.2
 ;;808^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MCC^2.2904^5.3^7.4
 ;;809^16^MED^MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH CC^1.2385^3.4^4.3
 ;;EXIT
